426219-42-3 Usage
Uses
Used in Organic Synthesis:
3-hydroxy-1-(1-trityl-1H-imidazol-4-yl)propan-1-one is used as a reagent for the synthesis of pharmaceuticals and other complex organic molecules. The trityl-protected imidazole group serves as a protecting group for imidazole nitrogen, while the 3-hydroxy-1-propanone group can participate in various chemical reactions to form a wide range of organic compounds.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 3-hydroxy-1-(1-trityl-1H-imidazol-4-yl)propan-1-one is used as a key intermediate in the synthesis of various drugs. Its unique structure and reactivity make it a valuable compound for the development of new medications with improved efficacy and selectivity.
Used in Organic Chemistry Research:
3-hydroxy-1-(1-trityl-1H-imidazol-4-yl)propan-1-one is also used in organic chemistry research to explore its synthetic utility and reactivity. Researchers utilize this compound to develop new synthetic methods and understand the underlying chemical reactions, contributing to the advancement of organic chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 426219-42-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,2,6,2,1 and 9 respectively; the second part has 2 digits, 4 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 426219-42:
(8*4)+(7*2)+(6*6)+(5*2)+(4*1)+(3*9)+(2*4)+(1*2)=133
133 % 10 = 3
So 426219-42-3 is a valid CAS Registry Number.
426219-42-3Relevant articles and documents
Novel imidazole derivatives, production method thereof and use thereof
-
, (2008/06/13)
The present invention provides a compound having a steroid C17,20-lyase-inhibitory activity and useful for the therapy and prophylaxis of tumor such as prostatism, breast cancer and the like, and a method for efficiently separating an optically active compound of this compound from a mixture of optical isomers thereof, a compound of the formula: wherein each symbol is as defined in the specification, a salt thereof or a prodrug thereof, and a method for obtaining an optically active compound by optically resolving a mixture of optical isomers by the use of a resolving agent such as tartranilic acid and the like.